Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Equity Ratio (2016 - 2025)

Veracyte (VCYT) has disclosed Equity Ratio for 14 consecutive years, with 0.93 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 2.97% to 0.93 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.93 through Dec 2025, up 2.97% year-over-year, with the annual reading at 0.93 for FY2025, 2.97% up from the prior year.
  • Equity Ratio hit 0.93 in Q4 2025 for Veracyte, up from 0.92 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.95 in Q1 2021 to a low of 0.9 in Q4 2024.
  • Historically, Equity Ratio has averaged 0.93 across 5 years, with a median of 0.93 in 2022.
  • Biggest five-year swings in Equity Ratio: rose 10.16% in 2021 and later fell 3.41% in 2024.
  • Year by year, Equity Ratio stood at 0.92 in 2021, then increased by 0.72% to 0.93 in 2022, then grew by 0.72% to 0.94 in 2023, then decreased by 3.41% to 0.9 in 2024, then grew by 2.97% to 0.93 in 2025.
  • Business Quant data shows Equity Ratio for VCYT at 0.93 in Q4 2025, 0.92 in Q3 2025, and 0.91 in Q2 2025.